RxDoctor Payments Data

Anil Magge, MD

Pulmonary Disease · Hartford, CTNPI 1295154821

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.5%), consulting fees and grants — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intuitive Surgical at 52.0% of the total. 2025 is the largest year on record at $26,959, more than ten times the $26 reported in 2019. Among pulmonary disease clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$73,649in general payments, 2019–2025

Across 137 payments — averaging $537.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$38K
  • Pulmonx Corporation$22K
  • Boston Scientific$9K
  • Noah Medical Corporation$2K
  • Medical Device Business Services, Inc.$1K
  • Pinnacle Biologics, Inc$765
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$18,22525%
  • Speaking & faculty fees$29,80040%
  • Grants$8,33311%
  • Travel & lodging$7,61210%
  • Food & beverage$6,4699%
  • Education$3,0214%
  • Gifts$1890%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,649 in reported general payments places this provider in the 90th percentile of 255 pulmonary disease providers in Connecticut.

See all pulmonary disease providers in Connecticut

Medicare billing

Part B allowed, 2024
$175,583
Medicare patients
320
Services billed
1,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,140
Albuterol Sulfate HfaAlbuterol Sulfate11$132
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$125
Prednisone32$53

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →